Financials in USD. Standardized financial statements.
A compact view of how IDEX Biometrics ASA turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $254,000 | $794,298 | $4.15M | $4.09M | $2.84M | $9.38M | $3.72M | $250,332 | $1.95M | $4.46M |
| Revenue Growth? | -68.0% | -80.9% | +1.5% | +44.1% | -69.7% | +152.0% | +1386.9% | -87.2% | -56.2% | 0.0% |
| Cost of Revenue? | $612,000 | $12.28M | $3.92M | $3.24M | $1.25M | $2.36M | $62,021 | $172,397 | $1.67M | $3.78M |
| Gross Profit? | -$358,000 | -$11.48M | $231,730 | $848,000 | $1.59M | $7.02M | $96,264 | $77,935 | $285,574 | $679,736 |
| Gross Margin? | -140.9% | -1445.5% | +5.6% | +20.7% | +55.8% | +74.9% | +2.6% | +31.1% | +14.6% | +15.2% |
| Operating Expenses? | $10.18M | $9.60M | $27.16M | $32.22M | $32.94M | $233.16M | $76.24M | $28.03M | $30.61M | $24.21M |
| Operating Income? | -$10.53M | -$21.08M | -$26.93M | -$31.37M | -$31.35M | -$226.13M | -$281.33M | -$247.09M | -$30.33M | -$23.53M |
| EBITDA? | -$8.57M | -$9.11M | -$273.86M | -$29.92M | -$29.54M | -$218.61M | -$273.12M | -$251.34M | -$242.56M | -$196.67M |
| Income Before Tax | -$10.04M | -$13.76M | -$270.55M | -$32.70M | -$32.46M | -$230.00M | -$283.22M | -$247.95M | -$30.61M | -$23.42M |
| Income Tax Expense | -$41,000 | -$113,336 | -$15,655 | -$36,000 | $90,000 | -$847,940.2 | $1.40M | $41,000 | $505,386 | $91,387 |
| Net Income? | -$10.00M | -$13.65M | -$26.71M | -$32.66M | -$32.55M | -$229.12M | -$32.42M | -$30.23M | -$31.11M | -$23.51M |
| EPS? | $-0.22 | $-1.93 | $-55.86 | $-76.37 | $-76.96 | $-713.47 | $-120.00 | $-116.00 | $-121.00 | $-96.87 |
| Diluted EPS? | $-0.22 | $-1.93 | $-55.86 | $-76.37 | $-76.96 | $-713.47 | $-120.00 | $-116.00 | $-121.00 | $-96.87 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality